Qui Tam Basics

Federal and State False Claims Act


Facts You Should Know About Qui Tam



Tax Whistleblower Laws



Securities and Commodities Whistleblower Laws



Articles


Whistleblower Stories



Resources


Contact Us About a Potential Case



Home


Qui tam Whistleblowers
This site provides news and information about the False Claims Act qui tam whistleblower law, the Tax Whistleblower law and the Securities and Commodities Whistleblower law. On this site you can learn the basics of each law and the process of bringing a case as well as read about the latest developments.

Getnick & Getnick LLP is a Manhattan-based law firm dedicated to business integrity and anti-fraud cases. Our whistleblower cases have resulted in recoveries of over a billion dollars for U.S. taxpayers.
Daily Blog Search


Advanced Blog Search

Monthly Archives
Most recent entries
Syndicate

Wednesday, December 21, 2011

Ranbaxy Laboratories to Pay $500 Million; Company Cuts Exec Pay

Ranbaxy Laboratories announced that it had made provision to pay $500 million in connection with a civil and criminal investigation by the Department of Justice relating to violations of the current Good Manufacturing Practices and falsification of records allowing the company to produce and sell medications that failed to meet FDA standards.  The drugs were then paid for by the President’s Emergency Plan for AIDS Relief program and distributed to foreign countries.  Subsequently, the FDA issued warning letters and banned over 30 medications produced by Ranbaxy plants in India.

Under the settlement, Ranbaxy entered into a Consent Decree with the FDA to improve its data integrity policies and procedures and comply with the cGMPs.

While allegations were pending, Ranbaxy was purchased by Japanese drugmaker Daiichi Sankyo for $4.6 billion.  Daiichi cut the pay of executives and directors and substantially reduced its profit forecast in anticipation of the $500 million settlement.

Read the entire article, “Ranbaxy Pays $500M For Manufacturing Problems"
“Ranbaxy Announces Consent Decree with U.S. Food and Drug Administration"

Posted by eithurburn on 12/21 at 12:42 PM
Permalink
Page 1 of 1 pages
Printer Friendly Printer Friendly Page
Disclaimer
This Site supported by Getnick & Getnick LLP Copyright © 2006

Designed, Developed and Maintained By Interactive Media Associates, Inc.